Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
about
Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerRank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populationsPrenatal sonographic diagnosis of urorectal septum malformation sequence and chromosomal microarray analysis: A case report and review of the literature.Genetic influences on hand osteoarthritis in Finnish women--a replication study of candidate genesChromosomal and genomic changes in lung cancer.Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyDrosophila ataxin 2-binding protein 1 marks an intermediate step in the molecular differentiation of female germline cysts.Admixture mapping of lung cancer in 1812 African-AmericansNon-clustered protocadherinGenetic association study between STK39 and CCDC62/HIP1R and Parkinson's diseaseSystematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.Genetic susceptibility to bladder cancer risk and outcome.A genome wide association study on Newfoundland colorectal cancer patients' survival outcomesAccurate computation of survival statistics in genome-wide studiesIdentification of novel vascular targets in lung cancer.Focus on 16p13.3 Locus in Colon CancerInterleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients.The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast CancerMolecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.Kernel machine SNP-set analysis for censored survival outcomes in genome-wide association studies.Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.Identification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing.MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersGenome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.An empirical workflow for genome-wide single nucleotide polymorphism-based predictive modelingGermline prognostic markers for urinary bladder cancer: obstacles and opportunities.Women and lung cancer: what is new?Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.Update in lung cancer and mesothelioma 2009.Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.Pharmacogenomics in the treatment of lung cancer: an update.Protocadherin 7 inhibits cell migration and invasion through E-cadherin in gastric cancer.PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.
P2860
Q28816916-E1C8A4F9-A930-4436-9894-8A810DA30161Q29417027-4F288EF8-3B2E-4760-893F-2BFBF2F3C14BQ30828384-2CDB9CB0-4EF4-4B77-91F7-17C018342AAEQ33604814-90F53FBF-0452-49A7-85A3-2A463D3AAA66Q33781119-70958437-41F0-42DC-84D2-9F8A953D4A0FQ33852594-FE9A7840-1CD6-4375-AFDF-7C885D7524B0Q34073818-3DEB1BB2-FF37-436A-B180-6B56890678BCQ34076429-C63D38BA-3CCC-48E9-B9EC-6407B61BBEE7Q34107589-9E00A7C8-BD38-4E0F-A550-A91E9076B6BEQ34617222-86685C24-4F5D-40B4-9256-98C922A2B13BQ34891159-3BD4DF7C-3A3A-4815-9EA9-B18DFA09DE20Q35060173-6D31E528-A707-4230-9152-4845EB256237Q35171191-D4164AE9-5247-4EE9-8DD3-5F1986C5789BQ35212792-3F955845-23DE-4D6B-B2AC-A29E135480BDQ35368806-5400DCB5-662B-4819-91CD-5CC6BDF48A1BQ35581820-F8DD6FF8-E0FD-4534-9753-20C71C8891D5Q35677838-84F7B257-973F-4B76-9086-BA1D914778B2Q35722912-070171B5-2072-468D-A2E8-4437DD81BDA0Q35762790-C6E77EF2-FD40-43E0-8CDB-926A8CB6B873Q35781316-A3F60B12-961A-4F3F-92A3-41B9754AF19AQ35844698-F13C7136-774A-4EA1-84CC-5ADAA5B7AFFAQ35900778-D998AB1F-0B6A-48F7-90D9-ED5F7C56BAD0Q36026743-F09256E3-07EB-4F04-ABFD-06CF5FFACBDFQ36214558-47887C12-AFB6-418E-A526-39E9632AAE62Q36545951-39990C29-1ED9-4FB5-A3D9-8EBFF609977AQ36698880-D7EF5799-9D59-4011-9CA5-0457C67BFD3CQ36706060-AF49FDEB-99E1-4060-87E0-F33A64BDD09AQ37037246-631213AF-AA1B-47C7-A922-8B37A11C43FEQ37045796-74DA0C94-CA89-486F-9A5A-4D85CF4C64C2Q37271395-AEA0B253-8A51-48A4-ACE3-9110C43204E0Q37298808-94A0F47C-C2A3-4C89-A8F7-FC6C4290D4E7Q37307499-617D77F2-926D-453B-B3BE-91E3CE0B6BC3Q37317557-725E4077-7CC7-4158-827C-86E2EFFEDA22Q37362585-AC39605F-19E3-46A6-8C66-3E81CFFC7C97Q37641613-E76FC62A-9DDE-452A-970C-79E76933E9E6Q37728779-343A5BCA-FC61-4545-BC30-6DCEB2AF6AE4Q37775627-420994F2-C258-40DF-8EC8-F6CCC2559185Q38596926-AEE073FB-27C2-411A-8CD0-BB4C0621E1BDQ38708786-0EF51DE2-66B0-47CB-B2C0-447C7D7550BEQ38732488-490BBB59-2FDE-434B-8AB1-2FFD97BDBD1E
P2860
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@en
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@nl
type
label
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@en
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@nl
prefLabel
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@en
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@nl
P2093
P2860
P356
P1476
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
@en
P2093
Aage Haugen
David C Christiani
Kofi Asomaning
Lucian R Chirieac
Michael C Wu
Rebecca S Heist
Shanbeh Zienolddiny
Vidar Skaug
Xihong Lin
P2860
P304
P356
10.1200/JCO.2008.18.7906
P407
P577
2009-05-04T00:00:00Z